458 related articles for article (PubMed ID: 14728026)
1. Effects of antihypertensive agents on the left ventricle: clinical implications.
Díez J; González A; López B; Ravassa S; Fortuño MA
Am J Cardiovasc Drugs; 2001; 1(4):263-79. PubMed ID: 14728026
[TBL] [Abstract][Full Text] [Related]
2. The importance of left ventricular hypertrophy in human hypertension.
Kahan T
J Hypertens Suppl; 1998 Sep; 16(7):S23-9. PubMed ID: 9855028
[TBL] [Abstract][Full Text] [Related]
3. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.
Schmieder RE; Martus P; Klingbeil A
JAMA; 1996 May; 275(19):1507-13. PubMed ID: 8622227
[TBL] [Abstract][Full Text] [Related]
4. Left ventricular hypertrophy and its regression: pathophysiology and therapeutic approach: focus on treatment by antihypertensive agents.
Schlaich MP; Schmieder RE
Am J Hypertens; 1998 Nov; 11(11 Pt 1):1394-404. PubMed ID: 9832187
[TBL] [Abstract][Full Text] [Related]
5. Goals of antihypertensive therapy.
McVeigh GE; Flack J; Grimm R
Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
7. The effect of combination therapy on regression of left ventricular hypertrophy in cases with hypertension.
Boydak B; Nalbantgil S; Yilmaz H; Zoghi M; Ozerkan F; Nalbantgil I; Onder R
Saudi Med J; 2004 Dec; 25(12):1975-8. PubMed ID: 15711679
[TBL] [Abstract][Full Text] [Related]
8. Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996).
Schmieder RE; Schlaich MP; Klingbeil AU; Martus P
Nephrol Dial Transplant; 1998 Mar; 13(3):564-9. PubMed ID: 9550628
[TBL] [Abstract][Full Text] [Related]
9. Regression of left ventricular hypertrophy--are there differences between antihypertensive agents?
Dahlöf B
Cardiology; 1992; 81(4-5):307-15. PubMed ID: 1363788
[TBL] [Abstract][Full Text] [Related]
10. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension.
Klingbeil AU; Schneider M; Martus P; Messerli FH; Schmieder RE
Am J Med; 2003 Jul; 115(1):41-6. PubMed ID: 12867233
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
Ruilope LM; Schmieder RE
Am J Hypertens; 2008 May; 21(5):500-8. PubMed ID: 18437140
[TBL] [Abstract][Full Text] [Related]
12. Selection of antihypertensive therapy: cardiac and extracardiac considerations.
Messerli FH; Soria F
Cardiology; 1992; 81(4-5):316-24. PubMed ID: 1301259
[TBL] [Abstract][Full Text] [Related]
13. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
Agabiti-Rosei E; Muiesan ML
J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
[TBL] [Abstract][Full Text] [Related]
14. Comparison of therapeutic studies on regression of left ventricular hypertrophy.
Schmieder RE; Schlaich MP
Adv Exp Med Biol; 1997; 432():191-8. PubMed ID: 9433526
[TBL] [Abstract][Full Text] [Related]
15. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.
Thomas GN; Chan P; Tomlinson B
Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636
[TBL] [Abstract][Full Text] [Related]
16. [Regression of left ventricular hypertrophy with antihypertensive treatment].
Galinier M; Bounhoure JP
Presse Med; 1990 Nov; 19(37):1715-9. PubMed ID: 1979167
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive drugs and the heart.
Diamond JA; Phillips RA
Curr Cardiol Rep; 2004 Nov; 6(6):409-15. PubMed ID: 15485599
[TBL] [Abstract][Full Text] [Related]
18. Diastolic blood pressure reduction contributes more to the regression of left ventricular hypertrophy: a meta-analysis of randomized controlled trials.
Zhang K; Chen J; Liu Y; Wang T; Wang L; Wang J; Huang H
J Hum Hypertens; 2013 Nov; 27(11):698-706. PubMed ID: 23535988
[TBL] [Abstract][Full Text] [Related]
19. Does the ADMA/DDAH/NO pathway modulate early regression of left ventricular hypertrophy with esmolol?
Quintana-Villamandos B; Delgado-Baeza E
Med Hypotheses; 2016 Feb; 87():44-7. PubMed ID: 26826640
[TBL] [Abstract][Full Text] [Related]
20. Real role of β-blockers in regression of left ventricular mass in hypertension patients: Bayesian network meta-analysis.
Xing F; Chen J; Zhao B; Jiang J; Tang A; Chen Y
Medicine (Baltimore); 2017 Mar; 96(10):e6290. PubMed ID: 28272254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
